HARROW HEALTH
Harrow Health, Inc. (Nasdaq: HROW) is an eye health pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible and affordable. For more information about Harrow Health, please visit the Investors section of the corporate website,www.harrowinc.com.
HARROW HEALTH
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
1998-01-01
Address:
Nashville, Tennessee, United States
Country:
United States
Website Url:
http://www.harrowinc.com
Total Employee:
101+
Status:
Active
Contact:
+1 615 733 4730
Email Addresses:
[email protected]
Total Funding:
98.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
SWK Funding
SWK Funding investment in Post-IPO Debt - Harrow Health
Life Sciences Alternative Funding
Life Sciences Alternative Funding investment in Post-IPO Debt - Harrow Health
Official Site Inspections
http://www.harrowinc.com
- Host name: server-52-85-151-64.iad89.r.cloudfront.net
- IP address: 52.85.151.64
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Harrow Health"
Harrow
We are supported by an integrated national sales and customer service organization, as well as an efficient, scalable, and tech-enabled national production and distribution platform licensed …See details»
Corporate Governance - Harrow, Inc.
Harrow is an organization with strong values of responsibility and integrity, including a commitment to the highest standards of legal and ethical business conduct – and we strive to …See details»
About - Harrow
Harrow Health, Inc. Changes Corporate Name to …
Sep 29, 2023 Investors Jamie Webb Director of Communications and Investor Relations [email protected] 615-733-4737 Media Deb Holliday Holliday Communications, Inc. [email protected] 412-877-4519See details»
Investor Relations - Harrow, Inc.
Nov 14, 2024 Harrow and its affiliate ImprimisRx currently serve over 10,000 doctors, hospitals, and ambulatory service centers through an integrated national sales and customer service …See details»
Harrow Health Launches New Corporate and Investor Website
NASHVILLE, Tenn., June 01, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused healthcare company, …See details»
Harrow Health - Crunchbase Company Profile & Funding
Harrow Health, Inc. (Nasdaq: HROW) is an eye health pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription …See details»
Harrow Health Launches New Corporate and Investor Website
NASHVILLE, Tenn., June 01, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused healthcare company, …See details»
Board of Directors | Harrow, Inc. - harrowinc.gcs-web.com
Dr. Makary has served in leadership at the World Health Organization and has been elected to the National Academy of Medicine. Dr. Makary has been a visiting professor at over 25 medical …See details»
Committee Composition | Harrow, Inc.
Address. 1A Burton Hills Blvd., Suite 200 Nashville, TN 37215. Phone (615) 733 4730 (615) 733 4737 (Investor Relations) SocialSee details»
Harrow Announces Nashville Expansion | Harrow, Inc.
Sep 25, 2024 Leading U.S. ophthalmic pharmaceutical company to create nearly 150 new jobs in Nashville. NASHVILLE, Tenn.--(BUSINESS WIRE)--Sep. 25, 2024-- Tennessee Governor …See details»
Harrow Company Profile | Management and Employees List
Harrow Profile and History. Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.See details»
Harrow Health Launches New Corporate and Investor Website
NASHVILLE, Tenn., June 01, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused healthcare company, …See details»
Harrow Health Publishes Corporate Transparency Report
Feb 8, 2022 Investor Contact: Jamie Webb, Director of Communications and IR [email protected] 615-733-4737 Site Navigation. Home. Home; Submit a Press Release; …See details»
Harrow - Overview, News & Similar companies | ZoomInfo.com
Who is Harrow. Founded in 2011 and headquartered in Nashville, Tennessee, Harrow is a growing leader in the ophthalmic healthcare market. Our success-to-date is d irectly tied to our …See details»
Harrow Licenses Canadian Rights to Apotex for Five Branded …
NASHVILLE, Tenn. & TORONTO, February 15, 2024--Harrow, Inc. (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, and Apotex Inc. ("Apotex"), Canada’s largest …See details»
Harrow Announces Participation in Upcoming Investor …
Nov 15, 2024 NASHVILLE, Tenn.--(BUSINESS WIRE)--Nov. 15, 2024-- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that …See details»
Harrow Health Launches New Corporate and Investor Website
Jun 1, 2021 For more information about Harrow Health, please visit the Investors section of the corporate website, harrowinc.com. Forward-Looking StatementsSee details»
Harrow Announces Second Quarter 2024 Financial Results
Jun 30, 2024 Conference Call and Webcast. The Company’s management team will host a conference call and live webcast tomorrow morning, Thursday, August 8, 2024, at 8:00 a.m. …See details»
Harrow Announces Third Quarter 2024 Financial Results
Nov 13, 2024 Third Quarter 2024 and Recent Selected Highlights: Revenues increased 44% from $34.3 million in the prior-year quarter to $49.3 million GAAP net loss of $(4.2) millionSee details»